Avidity Biosciences

$12.65 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Avidity Biosciences

Avidity Biosciences LLC operates as a biotechnology company. The Company develops and discovers novel antibody oligonucleotide conjugates therapeutics that overcome current barriers to the delivery of oligonucleotides and unlock their potential to treat a wide range of serious diseases. Avidity Biosciences serves customers in the United States.

Stock Analysis

last close $12.87
1-mo return -27.2%
3-mo return -13.8%
avg daily vol. 266.8T
52-week high 29.59
52-week low 11.02
market cap. $644M
forward pe -
annual div. -
roe -38.8%
ltg forecast -
dividend yield -
annual rev. $8M
inst own. 95.5%
baraka

Subscribe now for daily local and international financial news

Subscribe